0001818382-22-000201.txt : 20221212
0001818382-22-000201.hdr.sgml : 20221212
20221212161515
ACCESSION NUMBER: 0001818382-22-000201
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221208
FILED AS OF DATE: 20221212
DATE AS OF CHANGE: 20221212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scheessele William John
CENTRAL INDEX KEY: 0001879378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39532
FILM NUMBER: 221457270
MAIL ADDRESS:
STREET 1: 620 WADE AVENUE
STREET 2: UNIT 501
CITY: RALEIGH
STATE: NC
ZIP: 27605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Humacyte, Inc.
CENTRAL INDEX KEY: 0001818382
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851763759
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919-313-9633
MAIL ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20200716
4
1
wf-form4_167087968780298.xml
FORM 4
X0306
4
2022-12-08
0
0001818382
Humacyte, Inc.
HUMA
0001879378
Scheessele William John
2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM
NC
27713
0
1
0
0
Chief Commercial Officer
Stock Options (right to buy)
3.07
2022-12-08
4
A
0
136000
0
A
2032-12-08
Common Stock
136000.0
136000
D
The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026.
/s/ William John Scheessele by Dale A. Sander as Attorney-in-Fact
2022-12-12